Summit Therapeutics Market Sentiment

Summit Therapeutics Inc

SMMTNASDAQ

$16.33

2.1415.08%

Últ. Act.: Nov 6, 7:55 PM

Panorámica general Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Comparar Opciones Informe de acciones

Ganancias: Los beneficios de Q3 2026 se publicaron el mié nov 4th, después del cierre del mercado

Summit Therapeutics Market Sentiment - Benzinga

Summit Therapeutics Market Sentiment

Market sentiment signals for Summit Therapeutics (SMMT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 26.1% short float

Options Flow▲ 0.31 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

25 analysts

Options Flow (P/C)

0.31

More calls — Bullish

8,123 calls · 2,553 puts

Avg Consensus PT

$32

+95.5%

Highest Price Target

$44

+169.9%

Jefferies

Lowest Price Target

$12

-27.0%

Bernstein

Short Interest

26.1%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 1, 2026	Barclays	Etzer Darout—	+22.7%	$18 → $20	Maintained	Equal-Weight
Sep 29, 2026	Citigroup	Yigal Nochomovitz—	+163.8%	$40 → $43	Maintained	Buy
Sep 23, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	—	—	Maintained	Neutral
Sep 9, 2026	Jefferies	Faisal Khurshid—	+53.4%	$15 → $25	Upgrade	Hold→Buy
Aug 26, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	—	—	Maintained	Neutral
Aug 25, 2026	Bernstein	Jeffrey Walch—	-27.0%	$10 → $12	Upgrade	Underperform→Market Perform
Aug 18, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	—	—	Maintained	Neutral
Aug 12, 2026	Leerink Partners	Daina Graybosch—	-20.2%	$12 → $13	Upgrade	Underperform→Market Perform
Jul 24, 2026	Stifel	Dara Azar—	+133.1%	$45 → $38	Maintained	Buy
Jul 24, 2026	Guggenheim	Brad Canino—	+133.1%	$40 → $38	Maintained	Buy
Jul 23, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	—	—	Maintained	Neutral
May 22, 2026	Bernstein	Jeffrey Walch—	-52.8%	$8	Initiate	Underperform
May 22, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	—	—	Downgrade	Buy→Neutral
May 4, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+41.1%	$30 → $23	Maintained	Buy
May 1, 2026	Piper Sandler	Kelsey Goodwin—	-1.8%	$17 → $16	Maintained	Neutral
Apr 8, 2026	Stifel	Dara Azar—	+176.1%	$45	Initiate	Buy
Mar 16, 2026	Jefferies	Clara Dong—	-8.0%	$42 → $15	Downgrade	Buy→Hold
Feb 24, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+84.0%	$40 → $30	Maintained	Buy
Feb 2, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+145.4%	$40 → $40	Maintained	Buy
Jan 30, 2026	Citizens	Reni J. Benjamin—	+145.4%	$40 → $40	Maintained	Market Outperform
Dec 17, 2025	Barclays	Etzer Darout—	+10.4%	$16 → $18	Upgrade	Underweight→Equal-Weight
Nov 18, 2025	Wolfe Research	Kalpit Patel—	—	—	Initiate	Peer Perform
Oct 22, 2025	Guggenheim	Brad Canino—	+145.4%	$40 → $40	Maintained	Buy
Oct 21, 2025	Barclays	Etzer Darout—	-1.8%	$13 → $16	Maintained	Underweight
Oct 21, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	+145.4%	$50 → $40	Maintained	Buy

Summit Therapeutics Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Summit Therapeutics Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

People Also Watch

Bulls vs Bears

People Also Watch